OBJECTIVE: Treatment of schizophrenia has remained unsatisfactory despite the availability of antipsychotics. This study examined the efficacy of yoga therapy (YT) as an add-on treatment to the ongoing antipsychotic treatment. METHOD: Sixty-onemoderately ill schizophrenia patients were randomly assigned to YT (n = 31) and physical exercise therapy (PT; n = 30) for 4 months. They were assessed at baseline and 4 months after the start of intervention, by a rater who was blind to their group status. RESULTS: Forty-one subjects (YT = 21; PT = 20) were available at the end of 4 months for assessment. Subjects in the YT group had significantly less psychopathology than those in the PT group at the end of 4 months. They also had significantly greater social and occupational functioning and quality of life. CONCLUSION: Both non-pharmacological interventions contribute to reduction in symptoms, with YT having better efficacy.
RCT Entities:
OBJECTIVE: Treatment of schizophrenia has remained unsatisfactory despite the availability of antipsychotics. This study examined the efficacy of yoga therapy (YT) as an add-on treatment to the ongoing antipsychotic treatment. METHOD: Sixty-one moderately ill schizophreniapatients were randomly assigned to YT (n = 31) and physical exercise therapy (PT; n = 30) for 4 months. They were assessed at baseline and 4 months after the start of intervention, by a rater who was blind to their group status. RESULTS: Forty-one subjects (YT = 21; PT = 20) were available at the end of 4 months for assessment. Subjects in the YT group had significantly less psychopathology than those in the PT group at the end of 4 months. They also had significantly greater social and occupational functioning and quality of life. CONCLUSION: Both non-pharmacological interventions contribute to reduction in symptoms, with YT having better efficacy.
Authors: Triptish Bhatia; Akhilesh Agarwal; Gyandeepak Shah; Joel Wood; Jan Richard; Raquel E Gur; Ruben C Gur; Vishwajit L Nimgaonkar; Sati Mazumdar; Smita N Deshpande Journal: Acta Neuropsychiatr Date: 2011-08-10 Impact factor: 3.403
Authors: Eoin Killackey; Anna Lee Anda; Martin Gibbs; Mario Alvarez-Jimenez; Andrew Thompson; Pamela Sun; Gennady N Baksheev Journal: BMC Psychiatry Date: 2011-05-12 Impact factor: 3.630
Authors: Berend Malchow; Katriona Keller; Alkomiet Hasan; Sebastian Dörfler; Thomas Schneider-Axmann; Ursula Hillmer-Vogel; William G Honer; Thomas G Schulze; Andree Niklas; Thomas Wobrock; Andrea Schmitt; Peter Falkai Journal: Schizophr Bull Date: 2015-03-17 Impact factor: 9.306
Authors: Gerald J Jerome; Arlene T Dalcin; Deborah Rohm Young; Kerry J Stewart; Rosa M Crum; Carl Latkin; Bernadette A Cullen; Jeanne Charleston; Elisabeth Leatherman; Lawrence J Appel; Gail L Daumit Journal: Ment Health Phys Act Date: 2012-05-31